The World Infusion Pumps Market Will Reach $8.09bn In 2015 Predicts New Visiongain Report

14 September 2015
Pharma

A new report by visiongain predicts that the world infusion pumps market will reach $8.09bn in 2015. This forecast and others appear in Infusion Pumps Market: Prospects for Leading Companies 2015-2025, published in October 2015. Visiongain is a business information provider based in London, UK.

Infusion pumps deliver fluids, nutrients, and medications such as antibiotics, chemotherapy drugs, and pain relievers, into a patient’s body in controlled amounts. Generally, they are used intravenously, but arterial, subcutaneous (beneath the skin), and epidural (just within the surface of the central nervous system) infusions are occasionally used. The leading segment within the market is the insulin infusion segment, driven by an increasing incidence of diabetes. While the number of diabetes patients is only set to grow, the infusion pumps market has remained significantly under-penetrated, leading visiongain to believe there will be a number of opportunities for success in the next decade. We estimate the total infusion pumps market worth to reach $8.09bn in 2015.

Maria Kercheva, a pharmaceutical and medical devices industry analyst in visiongain, said: “In 2013, diabetes affected 381.8million people while 175 million remained undiagnosed. Furthermore, it was estimated that around 10% of Type I and a very small proportion of Type II diabetics in the US use insulin infusion pumps as their main source of insulin. Those figures, combined with an increasing pump adoption, prevalence of chronic diseases and unmet needs for technological advances will serve as market growth drivers. A strong pipeline of investigational pumps and other systems is discussed in this report and will undoubtedly change the infusion pumps landscape once commercialised. Additionally, opportunities for medical devices companies continue arising, as patients demand safer and more-reliable treatment options. The next decade will see advances in all sub-segments of the market and will create opportunities for companies that are ready to offer technological advances in the field.”

Included in the report is a lengthy discussion of the strengths and weakness of the field of infusion pumps, as well as the opportunities and threats facing developers. The report includes a forecast of the global infusion pumps market through to 2025, as well as forecasts for three submarkets:
• Insulin pumps,
• Enteral feeding pumps
• Other pumps (a grouped category inclusive of chemotherapy pumps and PCA infusion pumps)

National markets are also discussed, with forecasts to 2025 provided for the US, EU5 (Germany, UK, France, Italy and Spain), Japan, China, India, Brazil, Russia and South Korea.

This independent, 206-page report guarantees you will remain better informed than your competition. With 128 tables and figures examining the infusion pumps market space, the report gives you a visual, one-stop breakdown of your market. In addition, this report provides analysis of competing technologies, with forecasts to 2025 for the global drug delivery technologies market and the following submarkets:
• Oral drug delivery
• Inhalation drug delivery
• Injectable/implantable drug delivery
• Transdermal drug delivery
• Ocular drug delivery
• Nasal drug delivery

Infusion Pumps Market: Prospects for Leading Companies 2015-2025 adds to visiongain’s range of analytical reports on industries and markets in healthcare.

For an executive summary please contact:
Email: Sara Peerun on sara.peerun@visiongainglobal.com
Tel: +44 (0) 20 7336 6100

Notes for Editors

If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain

Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. From its head office in London, UK, visiongain produces a range of newsletters, business reports and e-zines covering current affairs and market trends in the Energy, Telecoms, Pharmaceutical, Defence, and Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high quality, original analyses to inform their strategic decisions.

Recent News

Visiongain Publishes Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2021-2031

Contract manufacturing outsourcing is gaining attraction owing to growing trend of outsourcing among pharmaceutical businesses.

16 November 2021

Read

Visiongain Publishes Biosimilars and Follow-On Biologics Market Report 2021-2031

The potential for digital & analytics applications in the pharmaceutical and biotechnology sector has grown dramatically in recent years as a result of fast technological advances as well as changes in the market environment & stakeholder behaviour as a result of the pandemic.

04 November 2021

Read

Visiongain Publishes Pharmaceutical Spray Drying Market Report 2021-2031

The rising prevalence of oncological disorders, lung infections, rising demand for customised drugs coupled with new orphan diseases discoveries, are few of the major reasons responsible for development of pharmaceutical spray drying market.

25 October 2021

Read

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever